Huntington disease (HD) has finally found its first successful treatment. Biotech company uniQure has announced positive top-line results from its Phase I/II trial of AMT-130. It is a one-time gene ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback